FDA Clearance Tracker · K231838
RxSight® Insertion Device (63002)
Last checked: Nov 20, 2026Latest source record: Aug 15, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Aug 15, 2023
Substantially Equivalent
Time to decision
54 days
Received Jun 22, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K231838
- Device name
- RxSight® Insertion Device (63002)
- Applicant
- Rxsight, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Jun 22, 2023
- Decided
- Aug 15, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 886.4300
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MSS. The earliest in FDA's data is K970727, decided Dec 17, 1997.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231838
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Rxsight, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261174 · Decided Jun 10, 2026 · 62 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
- RxSight Insertion Device510(k)
K231466 · Decided Jun 12, 2023 · 24 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
- RxSight Contact Lens510(k)
K201909 · Decided Sep 10, 2020 · 63 days after receipt
Device type: Lens, Contact, Polymethylmethacrylate, Diagnostic (HJK) · Ophthalmology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.